Boswellia studies reviewed
A Cochrane review examined five boswellia studies. Its strongest comparison found 100 mg of enriched boswellia improved pain and physical function after 90 days.
Explore the Cochrane reviewROB’S CHOICE / MOBILITY / THE RESEARCH
Boswellia reduces joint pain. Here’s the proof.
Human trials show enriched boswellia extract reduces knee pain and supports physical function. That is why 100 mg boswellia extract providing 30 mg AKBA leads Mobility’s daily formula.
49%IMPROVED KNEE-PAIN
SCORES AFTER 90 DAYS
SCORES AFTER 90 DAYS
01 / THE HUMAN TRIAL
49% improvement
after 90 days.
In a controlled trial, adults with knee osteoarthritis took 100 mg of a specific boswellia extract providing 30 mg AKBA every day. After 90 days, the 100 mg group’s standard knee-pain score improved by 48.83% compared with placebo.
See the trial and its results02 / THE WIDER EVIDENCE
The result stands on
more than one study.
Lower knee pain in a second trial
A separate controlled trial tested 100 mg of enriched boswellia daily and reported a 31.6% improvement in a standard knee-pain score versus placebo after 90 days.
See the second 90-day trial03 / INSIDE MOBILITY
Why these ingredients
are in Mobility.
100 mg boswellia extract
Boswellia leads the formula. It provides 30 mg AKBA: the same daily AKBA amount used in the lead 100 mg human trial.
200 mg moringa extract
Moringa adds antioxidant plant compounds alongside boswellia.
MAKE IT YOUR DAILY
One capsule.
One meal. Every day.
Mobility and Longevity bring two priorities into one complete daily routine.